Whitehawk Therapeutics, Inc.
WHWK
$4.26
-$0.13-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -25.18% | -9.41% | |||
| Gross Profit | 25.18% | 9.41% | |||
| SG&A Expenses | -17.07% | 7.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.01% | -5.48% | |||
| Operating Income | 23.01% | 5.48% | |||
| Income Before Tax | 25.02% | 4.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.02% | 4.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.02% | 4.55% | |||
| EBIT | 23.01% | 5.48% | |||
| EBITDA | 23.01% | 5.49% | |||
| EPS Basic | 37.37% | 4.55% | |||
| Normalized Basic EPS | 37.34% | 4.62% | |||
| EPS Diluted | 37.37% | 4.55% | |||
| Normalized Diluted EPS | 37.34% | 4.62% | |||
| Average Basic Shares Outstanding | 19.71% | 0.03% | |||
| Average Diluted Shares Outstanding | 19.71% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||